Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 20.08.2020
Manz AG
DGAP-Media / 20.08.2020 / 09:59
Manz AG: Order for second tranche from AKASOL for a module production line at US location
AKASOL confirms follow-up order for Gigafactory 2 at the Hazel Park site, USA
Positive project development for Gigafactory 1 at the AKASOL site in Darmstadt
Final acceptance of the line for Gigafactory 2 planned for t [ … ]
Thu, 20.08.2020
Rubean AG
Publication of inside information pursuant to Article 17 of Regulation (EU) No 596/2014
RUBEAN receives order from BBVA Bank for testing a mobile payment solution
- RUBEAN's PhonePOS solution is piloted in Spain
Munich and Madrid, 20. August 2020: The FinTech company RUBEAN AG, Munich, (ISIN: DE0005120802, WKN: 512080, R1B:GR) has receiv [ … ]
Thu, 20.08.2020
PANTAFLIX AG
PANTAFLIX with two additional B2B2C-customers: LUCAS and GOLDENER SPATZ rely on PANTAFLIX technology for their Film Festivals
Munich, August 20, 2020. PANTAFLIX AG (GSIN: A12UPJ, ISIN: DE000A12UPJ7) successfully acquired two additional festival operators as new business customers. PANTAFLIX will provide its streaming platform technology for the Ge [ … ]
Thu, 20.08.2020
GK Software SE
Turnover increases by approx. 12 percent
Significant increase in profitability
According to provisional figures, GK Software SE was able to continue its growth in turnover during the whole of the first half of 2020, despite the COVID-19 pandemic. The company was able to exceed the comparative results from the previous year by 11.7% or EUR 5.89 mil [ … ]
Thu, 20.08.2020
Heliad Equity Partners GmbH & Co. KGaA
Positive results according to IFRS due to write-ups of listed investments
NAV at EUR 10.74 per share
Flatex partial exit leads to double-digit earnings contribution for 2nd half year
Frankfurt am Main, den 20. August 2020 - Heliad Equity Partners GmbH & Co. KGaA (ISIN: DE000A0L1NN5) publishes today its figures for the first half of the 2020 [ … ]
Thu, 20.08.2020
Schaeffler AG
Extraordinary General Meeting of Schaeffler AG: Schaeffler AG Plans Creation of New Authorized Capital for up to 200 mil. New Shares
Herzogenaurach, August 20, 2020. Today, Schaeffler AG (ISIN DE000SHA0159, WKN SHA015) convenes an extraordinary general meeting for September 15, 2020 which will be held virtually in accordance with applicable COVID [ … ]
Thu, 20.08.2020
Schaeffler AG
Disclosure of inside information pursuant to Article 17 para 1 of the Regulation (EU) 596/2014 on market abuse (Market Abuse Regulation - MAR)Extraordinary General Meeting of Schaeffler AG: Schaeffler AG Plans Creation of New Authorized Capital for up to 200 mil. New SharesHerzogenaurach, August 20, 2020. Today, Schaeffler AG (ISIN DE000SHA0159, WK [ … ]
Thu, 20.08.2020
Mayr-Melnhof Karton AG
Solid business performance
Operating profit slightly below previous year
Focus on optimizing structural costs and deepening market penetration through innovation and product portfolio adjustments
Earnings in 2nd half-year expected to be further below previous year
The Mayr-Melnhof Group recorded an overall solid operating business performance al [ … ]
Thu, 20.08.2020
Global Fashion Group S.A.
GLOBAL FASHION GROUP DELIVERS HIGH GROWTH AND PROFITABLE, CASH FLOW POSITIVE SECOND QUARTER
Luxembourg, 20 August 2020 - Global Fashion Group S.A. ("GFG"), the leading online fashion and lifestyle destination in growth markets, delivers strong constant currency1 revenue and gross margin growth, its second Adj. EBITDA profitable quarter and record [ … ]
Thu, 20.08.2020
Centogene NV
CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
CAMBRIDGE, Mass., and ROSTOCK/BERLIN/HAMBURG, Germany, August 20, 2020 - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp [ … ]